Skip to main content

CytoDyn Inc.

CYDY
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001175680

No open-market purchases or sales by CytoDyn Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $35.2K in total; no superinvestor holds it.

Key figures

Market capNo recent closing price
–
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, −3 vs. previous quarter
6
13F valueReported value at the end of Q2 2026
$35.2K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2026
–
No comparable prior period
Net income, FY2026
-$42.7M
−1,240.2% year over year
Free cash flow, FY2026
–
No comparable prior period
Revenue, Q1 FY2027
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
36.2M
Shares sold short
Change
−111.0K
−0.3% vs. previous
Days to cover
5.76
At average daily volume

Superinvestors holding CYDY, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding CYDY at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by CytoDyn Inc. insiders from Form 4, newest first.

No open-market purchases or sales by CytoDyn Inc. insiders are on file.

Top 10 13F holders, Q2 2026

See all 6 holders

The largest institutional positions in CytoDyn Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding CYDY in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Diversified Trust Co45,790$10.9K0.00%00.0%Unchanged
Williams Jones Wealth Management, LLC.45,001$10.7K0.00%00.0%Unchanged
Next Capital Management LLC25,000$5.97K0.00%00.0%Unchanged
Horizon Financial Services, LLC18,200$4.35K0.00%00.0%Unchanged
Ancora Advisors, LLC9,488$2.27K0.00%00.0%Unchanged
Caz Investments LP4,000$9550.00%00.0%Unchanged